Tag: investment
-
Animal Genome Biotech Raises $9M in Seed Funds
A company discovering new drugs for a range of diseases based on the genomes of hibernating animals is raising $9 million in seed funds.
-
Infographic – Digital Therapeutics Funding on the Rise
The technology intelligence company CB Insights reported on new investments in digital therapeutics and found a record-setting funding pace this year.
-
Neuroscience Software Company Raises $23M in Early Funds
A company developing neuroscience data collection and analytics tools for clinicians and researchers raised $22.8 million in its first venture round.
-
Immunotherapy Biotech Gains $108M in New Funds
A company developing more precise immunotherapies for cancer and other diseases is raising $108 million in its second venture funding round.
-
Biotech Start-Up Gains $90M for Neurodegenerative Diseases
A one year-old biotechnology company developing treatments for diseases of microglia cells in the brain, is raising $90 million in new venture funds.
-
Psychedelic Therapy Company Raises $80M in New Funds
A developer of drugs from psychedelic compounds for mental health conditions is raising $80 million in its second venture funding round.
-
RNA Manufacturer Goes Public in $282M Merger
A company producing synthetic RNA for agricultural and biomedical applications is now a public company after a special-purpose acquisition.
-
Protein Chemistry Biotech Acquired in $2B Deal
Drug maker Bayer is acquiring a company discovering new therapies with a technology that reveals complex protein targets considered difficult to address.
-
Sanofi Acquires mRNA Developer in $3.2B Deal
Drug maker Sanofi is purchasing biotechnology company Translate Bio, a developer of messenger RNA vaccines and therapies, and a long-time collaborator.
-
Synthetic Blood Vessel Maker Gains $2.2M in Seed Funds
A start-up company creating synthetic blood vessels for transplants, based on research in materials science and cell biology, is raising $2.2 million in seed funds.